Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Eating Disorder Individualized Therapeutics-Naltrexone Neuroimaging (EDIT-N2)

NCT04935931 is registered in ClinicalTrials.gov with Children's Mercy Hospital Kansas City as lead sponsor.

NCT NCT04935931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04935931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Eating Disorder Individualized Therapeutics-Naltrexone Neuroimaging (EDIT-N2)
Lead sponsor
Children's Mercy Hospital Kansas City
Phase
Phase 1
Overall status
Completed
Start date
July 16, 2021
Completion date
June 30, 2022
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

binge eating, eating disorders, purging (eating disorders)